Announcement on Subsidiary Obtaining Notice of Approval for Drug Clinical Trials
Release time:
2021-05-20
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No: pro 2020-018
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Subsidiaries Obtaining Notice of Approval for Drug Clinical Trials
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Note:
- Company's approval notice for drug clinical trials will not have a significant impact on the company's recent operating results.
- Risk Warning: Due to the particularity of drug research and development, the pre-development of drugs and the long cycle and many links of products from development, clinical trials to production are susceptible to some uncertain factors, clinical trial progress, There are many uncertainties in the results and the future product market competition situation.
1. Summary
Recently, Zhejiang Jianfeng Yien Biotechnology Co., Ltd. (hereinafter referred to as "Jianfeng Yien") , , a holding subsidiary of Zhejiang Jianfeng Pharmaceutical Co., Ltd., the company's holding subsidiary, received the "Drug Clinical Trial Approval Notice" approved and issued by the State Food and Drug Administration, "JFAN-1001 Capsule, Notice No: 2020LP00246 " and "JFAN-1001 Capsules, Notification No: 2020LP00247 ". The relevant details are hereby announced as follows:
2. drug basic information content
drug name: JFAN-1001 capsule
English name: JFAN-1001Capsule
dosage form: capsule
application item: clinical research application
specification: 10mg , 30mg
registration classification: chemical drugs category
applicant: Zhejiang Jianfeng yien biotechnology co., ltd
approval conclusion: "according to the the People's Republic of China drug administration law and relevant regulations, after examination, 2020 6 February 7 accepted JFAN-1001 glue capsule meets the relevant requirements of drug registration and agrees to carry out clinical trials according to the submitted plan."
3. Drug Research and Development and Registration
JFAN-1001 is a new anti-tumor drug developed by Jianfeng Yien. The registration classification belongs to chemical drug 1 . Jianfeng Yien first submitted JFAN-1001 clinical trial application and was accepted on 2020 6 January 7 (acceptance numbers: CXHL2000255 , CXHL2000256 ). JFAN-1001 is a small molecule antineoplastic agent with indications for EGFR-T790M secondary mutation-positive locally advanced or metastatic non-squamous non-small cell lung cancer. As of the date of this announcement, the accumulated research and development expenses and technical investment of the project totaled about 4676.04 .03 million yuan.
Market Situation of Similar Drugs in 4.
Currently, targeted drugs for epidermal growth factor receptor (EGFR ) inhibitors listed in China include: the first generation EGFR inhibitors include gefitinib, erlotinib and icotinib; The second generation EGFR inhibitors include afatinib and dacotinib; the third generation EGFR inhibitor includes AstraZeneca's osimertinib, which was approved for listing in the United States on November 11, 2009, , , , and approved for listing in China on March 122, , 2017, . AstraZeneca global annual sales of osimertinib in 2019, , .7 billion (source: 2019# AstraZeneca Annual Financial Statement for 129), almetinib of Jiangsu Haosen Pharmaceutical Co., Ltd. was approved to be listed in China in January , March this year. The company's JFAN-1001 is the third generation EGFR inhibitor with the same target as osimertinib, at present, similar drugs in the clinical research stage include efitinib of Shanghai Alex pharmaceutical technology co., ltd., avetinib of Hangzhou essen pharmaceutical research co., ltd., Nanjing shenghe pharmaceutical co., ltd. SH-1028 , Jiangsu osaikang pharmaceutical co., ltd. ASK120067 , Jiangsu runxin biotechnology co., ltd. RX518 and many other enterprises. Approval Procedure for 5. Products to Be Listed Jianfeng Yien will conduct clinical trials according to the requirements of the Notice of Approval of Drug Clinical Trials. After the clinical trials are completed, production will be declared. Production and marketing can only be carried out after passing the review and approval of the State Food and Drug Administration and obtaining the approval documents for drug production. 6. Impact on Listed Companies and Risk Tips
The company's approval notice for drug clinical trials will not have a significant impact on the company's recent operating results. Due to the particularity of drug research and development, the pre-development of drugs and the long cycle and many links from development, clinical trials to production of products are easily affected by some uncertain factors. There are many uncertainties in the progress and results of clinical trials and the future product market competition situation. The company will be based on the progress of research and development in a timely manner to fulfill the obligations of information disclosure, so that the majority of investors pay attention to investment risks.
hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors August 19, 2020
More information
Passion to sing praises to the party
On June 26, the Jinhua United Front "Tongxin · Ode" chorus competition to celebrate the 100 anniversary of the founding of the Communist Party of China was held at the Jinhua Cultural Center Theater. The Jinhua City Federation of Industry and Commerce team, composed mainly of peak employees, won the bronze award for the song "Under the Brilliant Sunshine" in the competition.
2021
07-01
On the morning of July 1, a grand celebration of the 100 anniversary of the founding of the Communist Party of China was held in Tiananmen Square in Beijing. Xi Jinping, General Secretary of the CPC Central Committee, President of the State, and Chairman of the National Military Commission, delivered an important speech. At 8: 00 a.m. in the conference room of the peak building, members of the party Committee of the group company, members of the management team, functional departments and employees of subordinate enterprises working in the peak building were present on time to watch the live broadcast of the celebration. The subordinate enterprises of the company also organized party members and cadres to watch the live broadcast and celebrate the party's centtieth birthday in the form of raising the national flag and reviewing the oath of joining the party.
2021
07-01
Group Party Committee Visits Old Party Members
As the 100 anniversary of the founding of the Communist Party of China approaches, on June 9, the group party committee visited and expressed condolences to old party members and party members in difficulties, and sent them holiday blessings and greetings. The picture shows Qin Xuping, member of the group's party committee and director of the party and mass work department, on behalf of the group's party committee, expressing condolences to Xu Zeng, the first batch of employees and veteran party members of Jinhua cement factory, the predecessor of the peak, when it started its business in 1958.
2021
06-22
"I volunteer to join the Communist Party of China, support the party's program, abide by the party's constitution, fulfill the obligations of party members ......" On the morning of June 6, at the site of the Gutian Conference in Shanghang County, Fujian Province, more than 30 pinnacle party members solemnly raised their right fists facing the party flag to revisit the oath of joining the party. Visiting and studying the red education base and reviewing the oath of joining the party are important contents of the study and education of party history. Yu Jianhong, Qin Xuping and Chen Tianci, members of the group's party committee, party members of various branches of the group's headquarters, and secretaries of grass-roots party organizations under the group's party committee, totaling more than 30 people, visited and studied at the Gutian conference site. Party members visited the Gutian Conference site, the Chairman's Memorial Garden, the Gutian Conference Memorial Hall and other red attractions, and presented flower baskets to the statue of Comrade Mao Zedong. The Gutian Conference was the ninth party congress held by the Fourth Army of the Chinese Workers' and Peasants' Red Army in Gutian Village, Shanghang County, Fujian Province from December 28 to 29, 1929. This meeting summed up the experiences and lessons of army building since the founding of the fourth Red Army, established the principle of the party's absolute leadership over the Red Army, combined Marxism-Leninism with the concrete practice of China's revolutionary struggle, and solved the fundamental problem of how to maintain the party's proletarian vanguard nature and build a new type of people's army by strengthening the party's ideological work. It is of great significance in the history of the development of the Communist Party of China and the Workers' and the Red Army. During the visit and study, the party members visited the display of revolutionary cultural relics, listened to the explanation, got a close understanding of the revolutionary process of building the party and army under difficult conditions, and accepted the spiritual baptism of ideals and beliefs.
2021
06-11
Spike can independently determine the level of professional skills!
A few days ago, after the examination and approval of Jinhua Human Resources and Social Security Bureau, and reported to the Provincial Department of Human Resources and Social Security for examination and record, Zhejiang Jianfeng Group Co., Ltd. was approved to independently identify the level of vocational skills. High-skilled talents are an important part of the enterprise talent team, and they are the backbone to promote technological innovation and promote the transformation of modern scientific and technological achievements into real productivity. Therefore, Jianfeng Group attaches great importance to strengthening the construction of senior technicians, technicians, senior technicians and other talent teams and the training of skilled talents. In recent years, the entire group company has carried out various forms of skills training based on the improvement of employees' job skills. Last year alone, more than 8000 person-times of job skills training were held, which improved employees' professional skills and business capabilities. Under the background of digital and intelligent production, effectively stimulating front-line employees to learn skills and drill business, and cultivating and building a highly skilled workforce is one of the important means to promote the high-quality development of enterprises. At the beginning of the year, the human resources department of the group began to prepare to rely on the national vocational skill identification standards, and formulated the national vocational skill level independent identification scheme of Jianfeng group for the group's two main businesses of cement and pharmaceutical industry. after the comprehensive evaluation of the municipal human resources and social security bureau and Jinhua vocational skill management service center, the group company was agreed to become the independent identification unit of vocational skill level. The success of the application for the independent identification of the vocational skill level of the group company marks the company's skilled talent evaluation work, which has realized the transformation from government-led to the autonomy of employers, combining evaluation with training, use and incentives, and expanding the growth channel of skilled talents. It has laid a good foundation for promoting skill upgrading actions and building knowledge-based, skilled and innovative industrial workers. The positions independently identified by the group company's professional skill level are mainly in the two main businesses of cement and pharmaceutical industry, specifically cement production workers (including cement central controller, cement quality inspector, cement clinker calciner, cement manufacturer, cement production inspection worker, etc.) and pharmaceutical preparation workers. The group is about to carry out the independent identification of vocational skill levels for these two categories of work.
2021
05-21
On April 27, Qiandongnan Prefecture of Guizhou Province held a conference to celebrate the "May 1st" International Labor Day. Huangping Jianfeng Cement Company was awarded the May 1st Labor Certificate of Qiandongnan Prefecture at the conference. Tang Yueqiang, Secretary of the Party Leadership Group and Director of the Standing Committee of the People's Congress of Qiandongnan Prefecture, hoped in his speech that the broad masses of employees in the prefecture will keep in mind the ardent entrustment of General Secretary Xi Jinping, closely focus on the overall situation of the prefecture, consciously shoulder the glorious mission, and vigorously promote the spirit of model workers and labor. The spirit of craftsmanship and the spirit of Guizhou in the new era are striving to be knowledge, skilled and innovative workers in the new era, make new contributions and create new glories in the new journey of building socialist modernization. The conference named and commended the collectives and individuals who won the Qiandongnan May 1st Labor Award, the Worker Pioneer, and the Qiandongnan Craftsman Honors. 40 units including Huang Ping Jianfeng won the Qiandongnan Prefecture May 1st Labor Award. In addition, on the afternoon of May 7, Huangping County, Guizhou Province held the 2021 model worker and advanced worker commendation meeting to commend 11 model workers and 19 advanced workers. Qian Jiang, deputy secretary of the Jianfeng Party branch of Huangping and chairman of the trade union, was awarded the honor of "model worker" in Huangping County. Yang Zhi, deputy secretary of the Huangping County CPC Committee and county magistrate, called on the whole county to vigorously carry forward the spirit of model workers, labor spirit, and craftsmanship, so as to make it a common practice to advocate model workers, learn from model workers, and strive to be model workers, and further gather powerful forces to speed up the high-quality development of Huangping. As a model worker representative, Qian Jiang made an experience exchange speech at the conference.
2021
05-21